Health Technology Assessment (Jul 2005)
The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation
Abstract
No abstracts available.
Health Technology Assessment (Jul 2005)